PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: March 2018 Investor Presentation, page-45

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 782 Posts.
    lightbulb Created with Sketch. 66
    I have a feeling that this will keep going...I think there is a clearing of a backlog of holders that have been waiting for the opportunity to get out.
    With the results of the breast trial imminent...I think the market is anticipating good results.It is the achievement of market milestones..ie positive data that sends the SP higher...as it mitigates and derisks the future trials.
    It has a further positive effect on all our other trials in progress we are working with the same molecule PTX 200 in different ways.
    It also derisks the safety question that the market is wary of...good results in the breast cancer trial ie greater than 25% is very exciting for PTX.
    So lets wait and see.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.